Targeted Transcatheter Magneto-Mechanical Therapy for Hepatocellular Carcinoma

肝细胞癌的靶向经导管磁力机械治疗

• 批准号: 8584047
• 负责人: Dong-Hyun Kim
• 金额: $ 16.8万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-08-01 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8584047
• 关键词: Address; Apoptosis; Apoptotic; Autopsy; Binding; Biomedical Engineering; CD44 gene; Caliber; Cancer Biology; Cell Death; Cell Survival; Cell membrane; Cells; Characteristics; Data; Functional Magnetic Resonance Imaging; Hepatic; Hepatic artery; Image; Imaging Phantoms; Imaging Techniques; In Vitro; Infusion procedures; Injection of therapeutic agent; Magnetic Resonance Imaging; Magnetism; Malignant Epithelial Cell; Malignant Neoplasms; Measurement; Measures; Mechanics; Methods; Modeling; Monitor; Monitoring for Recurrence; Motion; Necrosis; Palliative Care; Patients; Primary carcinoma of the liver cells; Quantitative Microscopy; Radiology Specialty; Rattus; Recurrence; Relaxation; Rodent Model; Scheme; Solid Neoplasm; Surface; Techniques; Therapeutic; Tumor Burden; Tumor Tissue; Tumor Volume; Unresectable; Validation; Vascular blood supply; cancer cell; cancer therapy; dosage; effective therapy; follow-up; hepatoma cell; improved; in vivo; innovation; magnetic field; nanodisk; nanomagnetic; nanosized; neoplastic cell; novel therapeutics; outcome forecast; particle; public health relevance; response; tumor

DESCRIPTION (provided by applicant): The broad, long-term objective of this proposal is to improve the prognosis of patients with unresectable hepatocellular carcinoma (HCC). Current therapies are palliative and relatively ineffective for improving prognosis. There exists a critica need for improved methods for effective treatment. Our recent studies have demonstrated the exciting potential of an innovative new therapeutic option for solid tumors; our proposed approach involves using magnetic vortex disks that apply magneto-mechanical forces at the surface of targeted cell membranes to induce apoptotic cell death. We propose the first in vivo study to validate the anti-cancer efficacy of magneto-mechanical therapy for the treatment of HCC. Magnetic nanodisks will be fabricated and characterized for magneto-mechanical cell destruction. We will use transcatheter infusions to deliver the magnetic disks directly into the blood supply of the targeted hepatic tumors. In vivo targeting efficiency via transcatheter hepatic artery injection will be studied with MRI quantification and histological measurements in an HCC rat model. Finally, we will evaluate in vivo therapeutic responses of targeted transcatheter magneto-mechanical cancer therapy; we will validate the ability to induce apoptotic HCC cell death using anti-CD44 conjugated magnetic nanodisks in the rodent model. Through a collaborative project building upon our strengths in biomedical engineering, radiology, and cancer biology, we seek to develop a powerful new magneto-mechanical therapeutic method for the treatment of HCC. Our proposed project will address the following Specific Aims: Aim 1: To determine targeting efficiency and imaging characteristics of our nano magnetic disks Task 1.1: To fabricate various nano-sized magnetic spin-vortex disks (Au coated Fe disk) at a specific geometrical ratio for magneto-mechanical motion upon cell membrane. Task 1.2: Biofunctionalization of magnetic disks and validation of in vitro magneto-mechanical destruction of hepatocellular carcinoma cells. Task 1.3: To characterize relationship between magnetic nanodisks concentration and T2/T2* relaxations rates for magnetic resonance imaging (MRI). Aim 2: To validate that transcatheter magneto-mechanical cancer therapy leads to tumor regression in HCC rat models. Task 2.1: To determine in vivo targeting efficiency of magnetic nanodisks using both in vivo quantitative MRI measurements and invasive histological measurements at necropsy. Task 2.2. To demonstrate in vivo therapeutic responses to targeted transcatheter magneto-mechanical therapy with both functional MRI technique and pathological analysis of tumor cell death.

描述（由申请人提供）： 该建议的广泛、长期目标是改善不可切除的肝细胞癌（HCC）患者的预后。目前的治疗是姑息性的，对改善预后相对无效。存在对用于有效治疗的改进方法的迫切需要。我们最近的研究已经证明了实体瘤的创新性新治疗选择的令人兴奋的潜力;我们提出的方法涉及使用磁涡流盘，该磁涡流盘在靶细胞膜的表面施加磁机械力以诱导凋亡细胞死亡。我们提出了第一个在体内研究，以验证磁机械疗法治疗肝癌的抗癌疗效。磁性纳米盘将被制造和表征用于磁机械细胞破坏。我们将使用经导管输注将磁盘直接输送到目标肝肿瘤的血液供应中。经导管肝靶向的体内靶向效率 将在HCC大鼠模型中用MRI定量和组织学测量来研究动脉注射。最后，我们将评估靶向经导管磁机械癌症治疗的体内治疗反应;我们将验证在啮齿动物模型中使用抗CD 44缀合的磁性纳米盘诱导凋亡HCC细胞死亡的能力。通过建立在我们在生物医学工程，放射学和癌症生物学方面的优势的合作项目，我们寻求开发一种强大的新的磁机械治疗方法来治疗HCC。本研究的主要目的是：目的1：确定纳米磁盘的靶向效率和成像特性任务1.1：以特定的几何比制备各种纳米磁性自旋涡旋盘（Au涂层Fe盘），用于细胞膜上的磁机械运动。 任务1.2：磁盘的生物功能化和肝细胞癌细胞体外磁机械破坏的验证。 任务1.3：描述磁共振成像（MRI）中磁性纳米盘浓度与T2/T2* 弛豫率之间的关系。目的2：验证经导管磁机械治疗肝癌导致肝癌大鼠模型的肿瘤消退。 任务2.1：使用体内定量MRI测量和尸检时的侵入性组织学测量来确定磁性纳米盘的体内靶向效率。 任务2.2.通过功能性MRI技术和肿瘤细胞死亡的病理学分析来证明靶向经导管磁机械治疗的体内治疗反应。